725
Views
87
CrossRef citations to date
0
Altmetric
Review Article

Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification

&
Pages 179-193 | Received 25 Oct 2010, Accepted 28 Dec 2010, Published online: 25 Feb 2011

References

  • Adachi, T., Weisbrod, R. M., Pimentel, D. R., Ying, J., Sharov, V. S., Schoneich, C., et al. (2004). S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10:1200–1207.
  • Adams, G. B., Chabner, K. T., Alley, I. R., Olson, D. P., Szczepiorkowski, Z. M., Poznansky, M. C., et al. (2006). Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439:599–603.
  • Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., et al. (1999). Regulation of JNK signaling by GSTp. EMBO J 18:1321–1334.
  • Arai, F., Yoshihara, H., Hosokawa, K., Nakamura, Y., Gomei, Y., Iwasaki, H., et al. (2009). Niche regulation of hematopoietic stem cells in the endosteum. Ann N Y Acad Sci 1176:36–46.
  • Armstrong, R. N. (1997). Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10:2–18.
  • Axarli, I., Labrou, N. E., Petrou, C., Rassias, N., Cordopatis, P., Clonis, Y. D. (2009). Sulphonamide-based bombesin prodrug analogues for glutathione transferase, useful in targeted cancer chemotherapy. Eur J Med Chem 44:2009–2016.
  • Bakker, J., Lin, X., Nelson, W. G. (2002). Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J Biol Chem 277:22573–22580.
  • Baldini, M., Sacchetti, C. (1953). Effect of cystine and cysteine on human bone marrow cultured in medium deficient in amino acids [in French]. Rev Hematol 8:3–19.
  • Barrett, W. C., DeGnore, J. P., Konig, S., Fales, H. M., Keng, Y. F., Zhang, Z. Y., et al. (1999). Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38:6699–6705.
  • Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., Cowan, K. H. (1986). Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261:15544–15549.
  • Borch, R. F., Valente, R. R. (1991). Synthesis, activation, and cytotoxicity of aldophosphamide analogues. J Med Chem 34:3052–3058.
  • Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., et al. (2003). Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846.
  • Chambers, S. M., Shaw, C. A., Gatza, C., Fisk, C. J., Donehower, L. A., Goodell, M. A. (2007). Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5:e201.
  • Cheshier, S. H., Morrison, S. J., Liao, X., Weissman, I. L. (1999). In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A 96:3120–3125.
  • Ciaccio, P. J., Tew, K. D., LaCreta, F. P. (1991). Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. Biochem Pharmacol 42:1504–1507.
  • Cipolleschi, M. G., Dello Sbarba, P., Olivotto, M. (1993). The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82:2031–2037.
  • Comporti, M. (1989). Three models of free radical-induced cell injury. Chem Biol Interact 72:1–56.
  • Conant, C. G., Stephens, R. S. (2007). Chlamydia attachment to mammalian cells requires protein disulfide isomerase. Cell Microbiol 9:222–232.
  • Cowell, I. G., Dixon, K. H., Pemble, S. E., Ketterer, B., Taylor, J. B. (1988). The structure of the human glutathione S-transferase pi gene. Biochem J 255:79–83.
  • Davis, W., Jr., Ronai, Z., Tew, K. D. (2001). Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 296:1–6.
  • Demasi, M., Shringarpure, R., Davies, K. J. (2001). Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch Biochem Biophys 389:254–263.
  • Fiaschi, T., Cozzi, G., Raugei, G., Formigli, L., Ramponi, G., Chiarugi, P. (2006). Redox regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem 281:22983–22991.
  • Findlay, V. J., Townsend, D. M., Morris, T. E., Fraser, J. P., He, L., Tew, K. D. (2006). A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res 66:6800–6806.
  • Findlay, V. J., Townsend, D. M., Saavedra, J. E., Buzard, G. S., Citro, M. L., Keefer, L. K., et al. (2004). Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol Pharmacol 65:1070–1079.
  • Fratelli, M., Demol, H., Puype, M., Casagrande, S., Eberini, I., Salmona, M., et al. (2002). Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 99:3505–3510.
  • Furchgott, R. F., Vanhoutte, P. M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J 3:2007–2018.
  • Garcia, J., Han, D., Sancheti, H., Yap, L. P., Kaplowitz, N., Cadenas, E. (2010). Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem 285:39646–39654.
  • Gate, L., Majumdar, R. S., Lunk, A., Tew, K. D. (2004). Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. J Biol Chem 279:8608–8616.
  • Gildenhuys, S., Wallace, L. A., Burke, J. P., Balchin, D., Sayed, Y., Dirr, H. W. (2010). Class pi glutathione transferase unfolds via a dimeric and not monomeric intermediate: functional implications for an unstable monomer. Biochemistry 49:5074–5081.
  • Golemis, E. A., Tew, K. D., Dadke, D. (2002). Protein interaction-targeted drug discovery: evaluating critical issues. Biotechniques 32:636–638, 640, 642 passim.
  • Goplen, D., Wang, J., Enger, P. O., Tysnes, B. B., Terzis, A. J., Laerum, O. D., et al. (2006). Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 66:9895–9902.
  • Gravina, S. A., Mieyal, J. J. (1993). Thioltransferase is a specific glutathionyl mixed disulfide oxidoreductase. Biochemistry 32:3368–3376.
  • Haendeler, J. (2006). Thioredoxin-1 and post-translational modifications. Antioxid Redox Signal 8:1723–1728.
  • Hammond, C. L., Marchan, R., Krance, S. M., Ballatori, N. (2007). Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem 282:14337–14347.
  • Henderson, C. J., Smith, A. G., Ure, J., Brown, K., Bacon, E. J., Wolf, C. R. (1998). Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A 95:5275–5280.
  • Henderson, C. J., Wolf, C. R., Kitteringham, N., Powell, H., Otto, D., Park, B. K. (2000). Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase pi. Proc Natl Acad Sci U S A 97:12741–12745.
  • Hidalgo, C., Sanchez, G., Barrientos, G., Aracena-Parks, P. (2006). A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S-glutathionylation. J Biol Chem 281:26473–26482.
  • Hutchens, S., Manevich, Y., He, L., Tew, K. D., Townsend, D. M. (2010). Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO. Invest New Drugs [Epub Mar 16]
  • Iwasaki, H., Suda, T. (2009). Cancer stem cells and their niche. Cancer Sci 100:1166–1172.
  • Jang, Y. Y., Sharkis, S. J. (2007). A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110:3056–3063.
  • Ji, X., Tordova, M., O’Donnell, R., Parsons, J. F., Hayden, J. B., Gilliland, G. L., et al. (1997). Structure and function of the xenobiotic substrate-binding site and location of a potential non-substrate-binding site in a class pi glutathione S-transferase. Biochemistry 36:9690–9702.
  • Kavanagh, J. J., Gershenson, D. M., Choi, H., Lewis, L., Patel, K., Brown, G. L., et al. (2005). Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer. Int J Gynecol Cancer 15:593–600.
  • Kellen, E., Hemelt, M., Broberg, K., Golka, K., Kristensen, V. N., Hung, R. J., et al. (2007). Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 165:1221–1230.
  • Kohler, A., Schmithorst, V., Filippi, M. D., Ryan, M. A., Daria, D., Gunzer, M., et al. (2009). Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 114:290–298.
  • Kraggerud, S. M., Oldenburg, J., Alnaes, G. I., Berg, M., Kristensen, V. N., Fossa, S. D., et al. (2009). Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology. Pharmacogenet Genomics 19:751–759.
  • Lo Celso, C., Wu, J. W., Lin, C. P. (2009). In vivo imaging of hematopoietic stem cells and their microenvironment. J Biophotonics 2:619–631.
  • Lo, H. W., Ali-Osman, F. (2007). Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 7:367–374.
  • Lyttle, M. H., Satyam, A., Hocker, M. D., Bauer, K. E., Caldwell, C. G., Hui, H. C., et al. (1994). Glutathione-S-transferase activates novel alkylating agents. J Med Chem 37:1501–1507.
  • Manevich, Y., Feinstein, S. I., Fisher, A. B. (2004). Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci U S A 101:3780–3785.
  • Mannervik, B., Danielson, U. H. (1988). Glutathione transferases—structure and catalytic activity. CRC Crit Rev Biochem 23:283–337.
  • Miyamoto, K., Araki, K. Y., Naka, K., Arai, F., Takubo, K., Yamazaki, S., et al. (2007). Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1:101–112.
  • Naka, K., Muraguchi, T., Hoshii, T., Hirao, A. (2008). Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 10:1883–1894.
  • Naka, K., Ohmura, M., Hirao, A. (2007). Regulation of the self-renewal ability of tissue stem cells by tumor-related genes. Cancer Biomark 3:193–201.
  • Nakamura, S., Matsushima, M., Song, H., Kikuchi, M. (1996). A role of PDI in the reductive cleavage of mixed disulfides. J Biochem 120:525–530.
  • Nilsson, S. K., Johnston, H. M., Coverdale, J. A. (2001). Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97:2293–2299.
  • Noguera-Mazon, V., Lemoine, J., Walker, O., Rouhier, N., Salvador, A., Jacquot, J. P., et al. (2006). Glutathionylation induces the dissociation of 1-Cys D-peroxiredoxin non-covalent homodimer. J Biol Chem 281:31736–31742.
  • Okamura, T., Singh, S., Buolamwini, J., Haystead, T., Friedman, H., Bigner, D., et al. (2009). Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor. J Biol Chem 284:16979–16989.
  • Ou, W., Silver, J. (2006). Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. Virology 350:406–417.
  • Park, B., Lee, S., Kim, E., Cho, K., Riddell, S. R., Cho, S., et al. (2006). Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127:369–382.
  • Pihlajaniemi, T., Helaakoski, T., Tasanen, K., Myllyla, R., Huhtala, M. L., Koivu, J., et al. (1987). Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene. EMBO J 6:643–649.
  • Raimondi, S., Paracchini, V., Autrup, H., Barros-Dios, J. M., Benhamou, S., Boffetta, P., et al. (2006). Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164:1027–1042.
  • Reinemer, P., Dirr, H. W., Ladenstein, R., Huber, R., Lo Bello, M., Federici, G., et al. (1992). Three-dimensional structure of class pi glutathione S-transferase from human placenta in complex with S-hexylglutathione at 2.8 A resolution. J Mol Biol 227:214–226.
  • Rhee, S. G., Jeong, W., Chang, T. S., Woo, H. A. (2007). Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int Suppl S3–S8.
  • Romero, L., Andrews, K., Ng, L., O’Rourke, K., Maslen, A., Kirby, G. (2006). Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem J 400:135–141.
  • Rosario, L. A., O’Brien, M. L., Henderson, C. J., Wolf, C. R., Tew, K. D. (2000). Cellular response to a glutathione S-transferase P1-1 activated prodrug. Mol Pharmacol 58:167–174.
  • Rosen, L. S., Brown, J., Laxa, B., Boulos, L., Reiswig, L., Henner, W. D., et al. (2003). Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies. Clin Cancer Res 9:1628–1638.
  • Rosen, L. S., Laxa, B., Boulos, L., Wiggins, L., Keck, J. G., Jameson, A. J., et al. (2004). Phase 1 study of TLK286 (Telcyta) administered weekly in advanced malignancies. Clin Cancer Res 10:3689–3698.
  • Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., Weissman, I. L. (2007). Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447:725–729.
  • Rossi, R., Giustarini, D., Milzani, A., Dalle-Donne, I. (2006). Membrane skeletal protein S-glutathionylation and hemolysis in human red blood cells. Blood Cells Mol Dis 37:180–187.
  • Ruscoe, J. E., Rosario, L. A., Wang, T., Gate, L., Arifoglu, P., Wolf, C. R., et al. (2001). Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298:339–345.
  • Saavedra, J. E., Srinivasan, A., Buzard, G. S., Davies, K. M., Waterhouse, D. J., Inami, K., et al. (2006). PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. J Med Chem 49:1157–1164.
  • Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., et al. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596–2606.
  • Sanchez-Gomez, F. J., Diez-Dacal, B., Pajares, M. A., Llorca, O., Perez-Sala, D. (2010). Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1. Mol Pharmacol 78:723–733.
  • Sau, A., Pellizzari Tregno, F., Valentino, F., Federici, G., Caccuri, A. M. (2010). Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 500:116–122.
  • Sequist, L. V., Fidias, P. M., Temel, J. S., Kolevska, T., Rabin, M. S., Boccia, R. V., et al. (2009). Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. J Thorac Oncol 4:1389–1396.
  • Shaulian, E., Karin, M. (2001). AP-1 in cell proliferation and survival. Oncogene 20:2390–2400.
  • Shelton, M. D., Chock, P. B., Mieyal, J. J. (2005). Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 7:348–366.
  • Shelton, M. D., Kern, T. S., Mieyal, J. J. (2007). Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. J Biol Chem 282:12467–12474.
  • Singh, S., Okamura, T., Ali-Osman, F. (2010). Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCalpha enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells. Biochem Pharmacol 80:1343–1355.
  • Sohn, J., Rudolph, J. (2003). Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry 42:10060–10070.
  • Sugiyama, T., Kohara, H., Noda, M., Nagasawa, T. (2006). Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977–988.
  • Swiatkowska, M., Szymanski, J., Padula, G., Cierniewski, C. S. (2008). Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J 275:1813–1823.
  • Tager, M., Kroning, H., Thiel, U., Ansorge, S. (1997). Membrane-bound protein disulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Exp Hematol 25:601–607.
  • Tanaka, K., Pracyk, J. B., Takeda, K., Yu, Z. X., Ferrans, V. J., Deshpande, S. S., et al. (1998). Expression of Id1 results in apoptosis of cardiac myocytes through a redox-dependent mechanism. J Biol Chem 273:25922–25928.
  • Tew, K. D. (1994). Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313–4320.
  • Tew, K. D. (2007). Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol 73:1257–1269.
  • Tian, G., Xiang, S., Noiva, R., Lennarz, W. J., Schindelin, H. (2006). The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell 124:61–73.
  • Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., et al. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128:325–339.
  • Townsend, D., Tew, K. (2003). Cancer drugs, genetic variation, and the glutathione-S-transferase gene family. Am J Pharmacogenomics 3:157–172.
  • Townsend, D. M. (2007). S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7:313–324.
  • Townsend, D. M., Findlay, V. J., Fazilev, F., Ogle, M., Fraser, J., Saavedra, J. E., et al. (2006). A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol Pharmacol 69:501–508.
  • Townsend, D. M., Manevich, Y., He, L., Hutchens, S., Pazoles, C. J., Tew, K. D. (2009a). Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436–445.
  • Townsend, D. M., Manevich, Y., He, L., Xiong, Y., Bowers, R. R., Jr., Hutchens, S., et al. (2009b). Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response. Cancer Res 69:7626–7634.
  • Townsend, D. M., Shen, H., Staros, A. L., Gate, L., Tew, K. D. (2002). Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells. Mol Cancer Ther 1:1089–1095.
  • Vergote, I., Finkler, N., del Campo, J., Lohr, A., Hunter, J., Matei, D., et al. (2009). Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. Eur J Cancer 45:2324–2332.
  • Voso, M. T., Hohaus, S., Guidi, F., Fabiani, E., D’Alo, F., Groner, S., et al. (2008). Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia 22:1685–1691.
  • Wang, A. L., Tew, K. D. (1985). Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep 69:677–682.
  • Wang, J., Boja, E. S., Tan, W., Tekle, E., Fales, H. M., English, S., et al. (2001a). Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276:47763–47766.
  • Wang, T., Arifoglu, P., Ronai, Z., Tew, K. D. (2001b). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276:20999–21003.
  • Wetzelberger, K., Baba, S. P., Thirunavukkarasu, M., Ho, Y. S., Maulik, N., Barski, O. A., et al. (2010). Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids. J Biol Chem 285:26135–26148.
  • Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., et al. (2008). Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135:1118–1129.
  • Wink, D. A., Cook, J. A., Christodoulou, D., Krishna, M. C., Pacelli, R., Kim, S., et al. (1997). Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1:88–94.
  • Yang, Y., Shi, W., Cui, N., Wu, Z., Jiang, C. (2010). Oxidative stress inhibits vascular K(ATP) channels by S-glutathionylation. J Biol Chem 285:38641–38648.
  • Yin, Z., Ivanov, V. N., Habelhah, H., Tew, K., Ronai, Z. (2000). Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60:4053–4057.
  • Yu, C. X., Li, S., Whorton, A. R. (2005). Redox regulation of PTEN by S-nitrosothiols. Mol Pharmacol 68:847–854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.